4 ms·
I find this implausible. Surely pharmaceutical companies are as aware as anyone of the growing antibiotic-resistance problem and know that there will likely be
by pdabbadabba 10y ago
I find this implausible. Surely pharmaceutical companies are as aware as anyone of the growing antibiotic-resistance problem and know that there will likely be a return on their investments in new antibiotic research. Sure, these companies sometimes exhibit a bias towards short-term gains, but they also aren't run by morons. And if they are run by morons, I see some great start-up opportunities...
- radus 10y agoThe reason they are not profitable is because generally antibiotics are only taken for short time periods. Additionally, it is almost certain that new antibiotics will be obsoleted by the emergence of resistance. Spending hundreds of millions of dollars on bringing a drug to market is already a risky proposition, even more so when your drug will be consumed in low quantities and may be useless before the patent even expires.